Trials / Completed
CompletedNCT06646757
Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome Disability
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 803 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
EMPOWER-IBD aims to identify behavioral interventions to strengthen patients' self-efficacy for self-management as a mechanism to reduce IBD-related disability. This multisite, randomized controlled trial with 16 arms will randomize adults with moderate-to-severe IBD-related disability to a combination of four multimodal behavioral interventions to test their clinical effectiveness in reducing IBD-related disability and improving self-efficacy. The interventions are four existing, publicly available disease-specific self-help resources offered at no cost to the participants: a book, smart app, help center, and peer mentor. Participants will complete online surveys and may engage in virtual focus groups. Participants may receive an honorarium (e-gift card) and/or be entered into a lottery for a giftcards post-survey completion and focus group participation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | APP | 1\) My IBD Care (APP) is a free smartapp that supports patients' tracking of symptoms, medical appointments, and medications; self-paced behavioral change programs |
| BEHAVIORAL | CBT | 2\) "Coping with Crohn's and Colitis: A Patient and Clinician's Guide to CBT for IBD" (CBT) is an IBD-specific cognitive behavioral therapy (CBT) workbook (e-book or hardcopy) |
| BEHAVIORAL | HELP | 3\) IBD Help Center (HELP) is a resource operated by the Crohn's and Colitis Foundation (CCF) for individuals to connect with an information specialist via email, call, or online live chat at no cost |
| BEHAVIORAL | PEER | 4\) Power of Two (PEER) is a one-on-one peer mentoring program operated by the Crohn's \& Colitis Foundation |
Timeline
- Start date
- 2024-08-14
- Primary completion
- 2025-10-15
- Completion
- 2025-10-15
- First posted
- 2024-10-17
- Last updated
- 2026-01-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06646757. Inclusion in this directory is not an endorsement.